Drug Shortage Report for TRISENOX
Report ID | 115216 |
Drug Identification Number | 02407833 |
Brand name | TRISENOX |
Common or Proper name | TRISENOX 10MG/10ML 10X10ML |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ARSENIC TRIOXIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-05-13 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-06-03 |
Company comments | Item is to be discontinued - TRISENOX 12MG/6ML 10X6ML INJ SOL is now available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-05-14 | English | Compare |
v2 | 2020-05-14 | French | Compare |
v3 | 2021-05-06 | English | Compare |
v4 | 2021-05-06 | French | Compare |
v5 | 2022-02-24 | English | Compare |
v6 | 2022-06-03 | English | Compare |
v7 | 2022-06-03 | French | Compare |
Showing 1 to 7 of 7